Abstract:Hepatitis C virus (HCV) infection causes 500,000 deaths annually, associated with end-stage liver diseases. Investigations of the HCV life cycle widened the knowledge in virology, and here we discovered that two piperazinylbenzenesulfonamides inhibit HCV entry into liver cells. The entry process of HCV into host cells is a complex process, not fully understood, but characterized by multiple spatially and temporally regulated steps involving several known host factors. Through a high-content virus-infection screening analysis with a library of 1,120 biologically active chemical compounds, we identified SB258585, an antagonist of the serotonin receptor 6 (5-HT6), as a new inhibitor of HCV entry in liver-derived cell lines, as well as in primary hepatocytes. A functional characterization suggested a role for this compound, as well as for the compound SB399885 sharing a similar structure, as inhibitors of a late HCV entry step, modulating the localization of the co-receptor tight junction protein claudin 1 (CLDN1), in a 5-HT6 independent manner. Both chemical compounds induced an intracellular accumulation of CLDN1, reflecting export impairment. This regulation correlated with the modulation of protein kinase A (PKA) activity. The PKA inhibitor H89 fully reproduced these phenotypes. Furthermore, PKA activation resulted in increased CLDN1 accumulation at the cell surface. Interestingly, increase of CLDN1 recycling did not correlate with an increased interaction with CD81 or HCV entry. These findings reinforce the hypothesis of a common pathway shared by several viruses, which involves G-protein coupled receptor -dependent signaling in late steps of viral entry. IMPORTANCE The HCV entry process is highly complex and important details of this structured event are poorly understood. By screening a library of biologically active chemical compounds, we identified two piperazinylbenzenesulfonamides as inhibitors of HCV entry. The mechanism of inhibition was not through previously described activity of these inhibitors as antagonists of the serotonin receptor 6, but instead through modulation of PKA activity in a 5-HT6 independent manner, as proven by the lack of 5-HT6 in liver. We thus highlighted the involvement of PKA pathway in modulating HCV post-binding step entry and in the recycling of the tight junction protein claudin-1 (CLDN1) towards the cell surface. Our work underscores once more the complexity of HCV entry steps and suggests a role for PKA pathway as regulator of CLDN1 recycling, having an impact on both cell biology and virology.

Inhibitors of Endoplasmic Reticulum Α-Glucosidases Potently Suppress Hepatitis C Virus Virion Assembly and Release

Inhibition of Hepatitis C Virus Replication and Expression by Small Interfering Rna Targeting Host Cellular Genes

A novel small molecule inhibitor of hepatitis C virus entry

Inhibition of hepatitis C virus serine protease in living cells by RNA aptamers detected using fluorescent protein substrates

Host Apolipoprotein B Messenger RNA-editing Enzyme Catalytic Polypeptide-Like 3G is an Innate Defensive Factor and Drug Target Against Hepatitis C Virus

A Genetic Screen Identifies Interferon-Α Effector Genes Required to Suppress Hepatitis C Virus Replication.

2-((4-Arylpiperazin-1-yl)methyl)benzonitrile Derivatives as Orally Available Inhibitors of Hepatitis C Virus with a Novel Mechanism of Action

Discovering novel anti-HCV compounds with inhibitory activities toward HCV NS3/4A protease

Entry Inhibitors of Hepatitis C Virus

Inhibition of Hepatitis C Virus in Mice by a Small Interfering RNA Targeting a Highly Conserved Sequence in Viral IRES Pseudoknot

Disruption of Hepatitis C Virus RNA Replication Through Inhibition of Host Protein Geranylgeranylation

Identification and Analysis of Novel Inhibitors against NS3 Helicase and NS5B RNA-Dependent RNA Polymerase from Hepatitis C Virus 1b (Con1)

Gene Expression Profiling of Endoplasmic Reticulum Stress in Hepatitis C Virus-Containing Cells Treated with an Inhibitor of Protein Disulfide Isomerases

Small Interfering Rna-Mediated Inhibition of Hepatitis G Virus Gene Expression in Human Hepatoma Cell Huh-7

Recent advancement in small molecules as HCV inhibitors.

IDENTIFICATION OF PIPERAZINYLBENZENESULFONAMIDES AS NEW INHIBITORS OF CLAUDIN-1 TRAFFICKING AND HEPATITIS C VIRUS ENTRY.

The Hepatitis B Virus Ribonuclease H Is Sensitive to Inhibitors of the Human Immunodeficiency Virus Ribonuclease H and Integrase Enzymes

Inhibition of hepatitis C virus infection by DNA aptamer against envelope protein

Inhibition of Hepatitis C Virus Replication by GS-6620, a Potent C -Nucleoside Monophosphate Prodrug

Small Molecular Compounds That Inhibit Hepatitis C Virus Replication Through Destabilizing Heat Shock Cognate 70 Messenger RNA.

RNA Interference Effectively Inhibits Mrna Accumulation and Protein Expression of Hepatitis C Virus Core and E2 Genes in Human Cells